Atropine reversal of kainic acid-induced decrease in the leptazol convulsive threshold.
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D051379:Mice; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010433:Pentylenetetrazole / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D011956:Receptors, Cell Surface / Q000187:drug effects; D011963:Receptors, GABA-A; D012640:Seizures / Q000139:chemically induced*
D011759:Pyrrolidines; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D001285:Atropine; D007608:Kainic Acid; D010433:Pentylenetetrazole